UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 SCHEDULE 13D/A

                    Under the Securities Exchange Act of 1934
                                (Amendment No. 7)

                                ORTHOMETRIX, INC.
                                (Name of Issuer)

                         Common Stock, Par Value $.0005
                         (Title of Class of Securities)

                                   68750M-10-0
                                 (CUSIP Number)

                               Reynald G. Bonmati
                                  Premium Point
                             New Rochelle, NY 10801
                                 (914) 576-1595

                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                 August 15, 2005
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-2(g), check the
following box [ ].

Note: Schedules filed in paper format shall include a signed original and five
copies of this schedule, including all exhibits, should be filed with the
Commission. See ss.240.13d-7(b) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a person's initial
filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter disclosures
provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
"filed" for the purpose of Section 18 of the Securities Exchange Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act(however, see the Notes).







                                  SCHEDULE 13D

--------------------------------------------------------------------------------
1     NAMES OF REPORTING PERSONS
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

      Bones, LLC
--------------------------------------------------------------------------------
2     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
                                                                 (a) ( )
                                                                 (b) (x)
--------------------------------------------------------------------------------
3     SEC USE ONLY


--------------------------------------------------------------------------------
4     SOURCE OF FUNDS (SEE INSTRUCTIONS)

      WC

--------------------------------------------------------------------------------
5     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
      ITEMS 2(d) or 2(e) (  )
--------------------------------------------------------------------------------
6     CITIZENSHIP OR PLACE OF ORGANIZATION

      A Delaware limited liability company
--------------------------------------------------------------------------------
                       7          SOLE VOTING POWER
NUMBER OF
SHARES
BENEFICIALLY                      13,359,499
OWNED BY EACH
REPORTING
PERSON WITH
              ------------------------------------------------------------------
                       8          SHARED VOTING POWER

                                  0
              ------------------------------------------------------------------
                       9          SOLE DISPOSITIVE POWER

                                  13,359,499
              ------------------------------------------------------------------
                      10          SHARED DISPOSITIVE POWER

                                  0

--------------------------------------------------------------------------------
11            AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

              13,359,499

--------------------------------------------------------------------------------
12            CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
              SHARES (SEE INSTRUCTIONS) (  )

--------------------------------------------------------------------------------
13            PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

              30.6%
--------------------------------------------------------------------------------
14            TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

              00
--------------------------------------------------------------------------------





                           Statement on Schedule 13D/A

         This Amendment amends the Statement on Schedule 13D of the undersigned
filed with the Securities and Exchange Commission on June 15, 2001 (the
"Original Statement") with respect to the beneficial ownership by the reporting
person of shares of common stock, $.0005 par value per share("Common Stock"), of
Orthometrix, Inc., a Delaware corporation (the "Issuer"). The filing of this
Amendment is occasioned by an exercise of stock options for Common Stock of the
Issuer by Bones LLC. Except as set forth herein, the information provided in the
original statement is unchanged.

ITEM 1.         SECURITY AND ISSUER.

         This statement relates to the Common Stock of the Issuer, Orthometrix,
Inc. The principal executive office of the Issuer is located at 106 Corporate
Park Drive, Suite 102, White Plains, New York 10604.

ITEM 2.         IDENTITY AND BACKGROUND.

         Bones, LLC ("Bones") is a Delaware limited liability company with its
principal business and office address at Premium Point, New Rochelle, New York
10801. The principal business of Bones is that of a private investment firm.
Reynald G. Bonmati a managing member of Bones.

         During the past five years, the reporting person, including any of its
executive officers or directors, has not (a) been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors), or (b) been
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws, or finding
any violations with respect to such laws.





ITEM 3.         SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

         Bones exercised stock options in the amount of $102,000 for its
purchase of 680,000 shares of Common Stock of the Issuer on August 15, 2005.

ITEM 4.         PURPOSE OF TRANSACTION.

            This Amendment is being filed as a result of the transactions
described above. The reporting persons have no present plans or proposals that
relate to or would result in or cause:

         (a)    the acquisition by any person of additional securities of the
                Issuer, or the disposition of securities of the Issuer;

         (b)    an extraordinary corporate transaction, such as a merger,
                reorganization or liquidation, involving the Issuer or any of
                its subsidiaries;

         (c)    a sale or transfer of a material amount of assets of the Issuer
                or any of its subsidiaries;

         (d)    any change in the present board of directors or management of
                the Issuer, including any plans or proposals to change the
                number or term of directors or to fill any existing vacancies on
                the board;

         (e)    any material change in the present capitalization or dividend
                policy of the Issuer;

         (f)    any other material change in the Issuer's business or corporate
                structure;

         (g)    changes in the Issuer's charter, bylaws or instruments
                corresponding thereto or other actions which may impede the
                acquisition of control of the Issuer by any person;

         (h)    a class of securities of the Issuer being de-listed from a
                national securities exchange or to cease to be authorized to be
                quoted in an interdealer quotation system of a registered
                national securities association;

         (i)    a class of equity securities of the Issuer becoming eligible for
                termination of registration pursuant to Section 12(g)(4) of the
                Securities Exchange Act of 1934; or

         (j)    any action similar to any of those enumerated above.

         The filing person reserves the right to adopt such plans and proposals
subject to applicable regulatory requirements, if any; and to transfer
securities of the Issuer directly and/or sell securities of the Issuer in the
open market.





ITEM 5.         INTEREST IN SECURITIES OF THE ISSUER.

         (a) As of August 15, 2005, there were 43,657,368 shares of Common Stock
of the Issuer outstanding. On August 15, 2005, Bones exercised stock options and
was issued 680,000 shares of Common Stock of the Issuer. Bones may currently be
deemed to beneficially own 13,359,499 shares of the Issuer's Common Stock, which
represents 30.6% of the outstanding Common Stock.

         (b) Bones has sole power to vote and dispose of 13,359,499 shares of
Common Stock representing 30.6% of the outstanding Common Stock.

         (c) There have been no transactions in securities of the Company
effected during the past sixty days by the undersigned other than as described
herein.

         (d) Except as set forth in this Amended Statement, no other person is
known to have the right to receive or the power to direct the receipt of
dividends from, or the proceeds from the sale of, the securities of, the Issuer
that are owned beneficially by the reporting persons.

         (e) Item 5(e) is not applicable to this Amended Statement.


ITEM 6.         CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
                RESPECT TO THE SECURITIES OF THE COMPANY

                N/A

ITEM 7.         MATERIAL TO BE FILED AS EXHIBITS.

                N/A

                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


Date: August 17, 2005


                                           Bones, LLC.



                                           /s/ Reynald G. Bonmati
                                           --------------------------
                                           Reynald G. Bonmati
                                           Managing Member